Figure 1From: Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients Percentage of CD4 + CD28 neg subset in ABA-treated patients. CD4+CD28neg cell percentage analyzed before (T0) and after 12 months of therapy with ABA.Back to article page